Publications by authors named "Asaf Ness"

Claim this Profile
R
Recent Trends and Predictors of Antibiotic Resistance in Helicobacter pylori in Israel.
Asaf Ness, Noa Eliakim-Raz, Rachel Gingold Belfer, Ram Dickman, Zohar Levi

Isr Med Assoc J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population-Based Propensity-Score-Adjusted Analysis.
Asaf Ness, Zohar Levi, Rachel Gingold Belfer, Ram Dickman, Doron Boltin

Helicobacter· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study.
Barak Pertzov, Einat Shmueli, Haim Ben Zvi, Amir Massarweh, Tamar Barkan, Asaf Ness

Respir Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study.
Noa Eliakim-Raz, Amos Stemmer, Yaara Leibovici-Weisman, Asaf Ness, Muhammad Awwad

BMJ Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.
Noa Eliakim-Raz, Amos Stemmer, Nassem Ghantous, Asaf Ness, Muhammad Awwad

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.
Erez Bar-Haim, Noa Eliakim-Raz, Amos Stemmer, Hila Cohen, Uri Elia, Asaf Ness

J Clin Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.
Noa Eliakim-Raz, Yaara Leibovici-Weisman, Amos Stemmer, Asaf Ness, Muhammad Awwad

JAMA· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis